ArticleHemaSphere2021

Rituximab Maintenance Versus Observation After Immunochemotherapy (R-CHOP, R-MCP, and R-FCM) in Untreated Follicular Lymphoma Patients: A Randomized Trial of the Ostdeutsche Studiengruppe Hämatologie und Onkologie and the German Low-Grade Lymphoma Study Group.

Carsten Hirt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.